VII. BIBLIOGRAFIA
148 | Perfil anticonvulsivante da lamotrigina em ratos
BIBLIOGRAFIA
ANDRÉ, V.; HENRY, D.; NEHLING, A. (2002) – Dynamic Variations of Local
Cerebral Blood in Maximal Electroshock Seizures in the Rat. Epilepsia. 43:10
(2002) 1120-1128.
ARAGÃO, M.J. (1993) - Experimentação Animal – A Ética e a Prática. Rev. Port.
Clín. Ger. Vol.10 nos 8 e 9 (1993) 184-190.
BACKONJA, M. [et al.] (1998) – Gabapentin for the symptomatic treatment of
painful neuropathy in patients with diabetes mellitus. JAMA. 280 (1998) 18311836.
BATTINO, D. [et al.] (2001) – Single-Dose Pharmacokinetics of Lamotrigine in
Children: Influence of Age and Antiepileptic Comedication. Ther. Drug Monit.
23:3 (2001) 217-222.
BERTRAND, P.; DUBAS, F. (1990) – Épilepsies: étiologie, diagnostic, évolution,
pronostic et principes du traitement. Nouv. Quest. 2:6 (1990) 23-29.
BLUME, W.T.; WOLF, P. (1997) – Introduction to the Epilepsies. In ENGEL, J.;
PEDLEY, T.A. ed. lit. - Epilepsy: A Comprehensive Textbook. Philadelphia:
Lippincott-Raven Publishers, 1997. Vol 1, chapter 67: p.765-771.
BRAGA, M.F.M. [et al.] (2002) – Lamotrigine reduces spontaneous and evoked
GABAA receptor-mediated synaptic transmission in the basolateral amygdala:
implications for its effects in seizure and affective disorders. Neuropharmacol. 42
(2000) 522-529.
BRODIE, M.J. (1992) – Lamotrigine. Lancet. 339:8806 (1992) 1397-1400.
BROWNING, R.A.; NELSON, D.K. (1985) – Variation in threshold and pattern of
electroshock-induced seizures in rats depending on site of stimulation. Life
Sciences. 37 (1985) 2205-2211.
VII. BIBLIOGRAFIA | 149
BRUNBECH, L.; SABERS, A. (2002) – Effect of Antiepileptic Drugs on Cognitive
Function in Individuals with Epilepsy - A Comparative Review of Newer Versus
Older Agents. Drugs. 62:4 (2002) 593-604.
CASTEL-BRANCO, M.M. (2002) – Caracterização neurofarmacocinética da
lamotrigina em ratos. Coimbra. Laboratório de Farmacologia; Faculdade de
Farmácia, Universidade de Coimbra, 2003. Tese de doutoramento.
CASTEL-BRANCO, M.M. et al. (2002a) – Influence of administration vehicles and
drug formulations on the pharmacokinetic profile of lamotrigine in rats. Fund.Clin.
Pharmacol. 16 (2002) 1-6.
CASTEL-BRANCO, M.M. et al. (2002b) – Lamotrigine pharmacokinetics in the
blood and brain of rats. The pharmacologist. 44: 2 (2002b) suppl 1.
CASTEL-BRANCO, M.M. et al. (2003a) – Lamotrigine Kidney distribution in male
rats following a single intraperitoneal dose. Fund. Clin. Pharm. 17 (2003a) 1-5.
CASTEL-BRANCO, M.M. et al. (2003b) – Anticonvulsant profile of lamotrigine in
rats following a single intraperitoneal dose. J. Veterinary Pharmacol. Ther.
26:suppl l (2003b) 167-168.
CASTEL-BRANCO, M.M. et al. (2003c) – Relationship between plasma and brain
levels and the anticonvulsant effect of lamotrigine in rats. Eur. J. Pharm. 15:482
(1-3) (2003c) 163-168.
CHEN, C.; VERONESE, L.; YIN, Y. (2000) – The effects of Lamotrigine on the
pharmackinetics of lithium. Br. J. Clin. Pharmacol. 50 (2000) 193-195.
CHOI, H.; MORRELL, M.J. (2003) – Review of lamotrigine and its clinical
applications in epilepsy. Expert. Opin. Pharmacother. 4:2 (2003) 1-9.
COHEN, A.F. [et al.] (1987) – Lamotrigine, a new anticonvulsant: Pharmacokinetics
in normal humans. Clin. Pharmacol. Ther. 42:5 (1987) 535-541.
COULTER, D.A. (1997) – Antiepileptic Drug Cellular Mechanisms of Action: Where
Does Lamotrigine Fit In? J. Child. Neurol. 12:suppl 1 (1997) S2-S9.
150 | Perfil anticonvulsivante da lamotrigina em ratos
CUNNINGHAM, M.O.; JONES, R.S.G. (2000) – The anticonvulsant lamotrigine
decreases spontaneous glutamate release in the rat entorhinal cortex in vitro.
Neuropharmacol. 39:11 (2000) 2139-2146.
DALBY, N.O.; NIELSEN, E.B. (1997) – Comparison of the preclinical anticonvulsant
profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res. 28:1
(1997) 63-72.
DERENDORF, H.; MEIBOHM, B. (1999) – Modeling of Pharmacokinetic/
/Pharmacodynamic (PK/PD) Relationships: Concepts and Perspectives. Pharm.
Res. 16:2 (1999) 176-185.
DIAS, M.S. (1992) – Epilepsia: Considerações sobre a doença e o seu tratamento.
Farmácia Port. 76:7/8 (1992) 37-43.
DREIFUSS, F.E. (1997) – Classification of Epileptic Seizures. In ENGEL, J.; PEDLEY,
T.A. ed. lit.-Epilepsy: A Comprehensive Textbook. Philadelphia:Lippincott-Raven Publishers, Raven Publishers, 1997. Vol 1, chapter 44: p.517-524.
ELWES, R.D.C.; BINNIE, C.D. (1996) – Clinical Pharmacokinetics of Newer
Antiepileptic Drugs: Lamotrigine, Vigabatrin, Gabapentin and Oxacarbazepine.
Clin. Pharmacokinet. 30:6 (1996) 403-415.
EINSENBERG, E. [et al.] (2001) – Lamotrigine reduces painful diabetic neuropathy.
Neurol. 57:8 (2001) 505-509.
ENGEL, J.J.; PEDLEY, T.A (1997) – Introduction : What is Epilepsy ?. In ENGEL, J.;
PEDLEY, T.A. ed. lit. – Epilepsy: A Comprehensive Textbook. Philadelphia:
Lippincott-Raven Publishers, 1997. Vol 1, chapter1: p.1-7.
ENGLE, P.M.; HECK, A.M. (2000) – Lamotrigine for the treatment of bipolar
disorder. Ann. Pharmacother. 34:2 (2000) 258-262.
ESTEVES, A.; GARRETT, C. (2001) – Antiepilépicos. In OSSWALD, W.; GUIMARÃES,
S. – Terapêutica Medicamentosa e suas Bases farmacológicas. 4ªed. Porto: Porto
Editora, 2001 Cap.18: p.222-226.
VII. BIBLIOGRAFIA | 151
FILIPE, C.N. (1997) – Mecanismos básicos das epilepsias. Rev. Port. Pedopsiq. 12
(1997) 29-46.
FIRMINO, H.; MARQUES, R. (1991) – Aspectos Psicossociais do Doente Epiléptico.
Médice. 9 (1991) 11-13.
FITTON, A.; GOA K.L. (1995) – Lamotrigine. An Update of its Pharmacology and
Therapeutic Use in Epilepsy. Drugs. 50:4 (1995) 691-713.
GIBBS, J.W. [et al.] (2002) – Anticonvulsant Actions of Lamotrigine on
Spontaneous Thalamocortical Rhythms. Epilepsia. 43:4 (2000) 342-349.
GILMAN, J.T. (1995) - Lamotrigine: An antiepileptic agent for the treatment of
partial seizures. Ann. Pharmacother. 29:2 (1995) 144-151.
GIORGI [et al.] (2001) – The Tolerability of Lamotrigine in Elderly Patients with
Epilepsy. Drugs & Aging. 18:8 (2001) 621-630.
GLUCK, M.R. [et al.] (2000) – CNS oxidative stress associated with the Kainic acid
rodent model of experimental epilepsy. Epilepsy Res. 39 (2000) 63-71.
GOA, K.L.; ROSS, S.R.; CHRISP, P. (1993) – Lamotrigine: A Review of its
Pharmacological Properties and Clinical Efficacy in Epilepsy. Drugs. 46:1 (1993)
152-176.
GOODMAN, L.S. [et al.] (1958) – Comparison of maximal seizures evoked by
pentylenetetrazol (metrazol) and electroshock in mice, and their modification by
anticonvulsants. J. Pharmacol. Exp. Ther. 108 (1958) 428-436.
HALONEN, T.; NISSINEN, J.; PITKÄNEN, A. (2001) – Effect of lamotrigine treatment
on status epilepticus-induced neuronal damage and memory impairment in rat.
Epilepsy Res. 46 (2001) 205-223.
HAUGVICOVÁ, R.; KUBOVÁ, H.; MAREĂS, P. (1998) – Qualitative changes of
anticonvulsant action of felbamate during development in rats. Brain &
Development. 20 (1998) 222-226.
152 | Perfil anticonvulsivante da lamotrigina em ratos
HURLEY, S.C. (2002) – Lamotrigine Update and its Use in Mood Disorders. Ann.
Pharmacoter. 86:5 (2002) 860-873.
KNOWLES, M.; HWANG, S. (1995) – The Influence of the Shape of the Plasma Drug
Concentration Profile Upon the Pharmacological Effect. Pharm. Res. 12:1 (1995)
168-170.
KULLMANN, D.M. (2002) – Genetics of Epilepsy. J. Neurol. Neurosurg.
Psychiatry. 73:Suppl II (2002) ii32-ii35.
KWAN, P.; SILLS, G.P.; BRODIE, M.J. (2001) – The mechanisms of action of
commonly used antiepileptic drugs. Pharmacol. Ther. 90:1 (2001) 21-34.
LAFFAN, R.J.; SWINYARD, E.A.; GOODMAN, L.S. (1957) – Stimulus intensity,
maximal electroshock seizures, and potency of anticonvulsants in rats. Arch. Int.
Pharmacodyn. Ther. 111 (1957) 60-69.
LAMB, R.J. et al. (1986) – Anticonvulsant profile in mice of lamotrigine, a novel
anticonvulsant. Br. J. Pharmacol. 85 (1985) 235P.
LEACH, M.J.; BAXTER, M.G.; CRITCHLEY, M.A. (1991) – Neurochemical and
Behavioral Aspects of Lamotrigine. Epilepsia. 32:Suppl 2 (1991) S4-S8
LEACH, M.J.; MARDEN, C.M.; MILLER, A.A. (1986) – Pharmacological Studies on
Lamotrigine, A Novel Potential Antiepileptic Drug: II. Neurochemical Studies on
the Mechanism of Action. Epilepsia. 27:5 (1986) 490-497.
LIN, J.; YAMAZAKI, M. (2003) – Role of P-Glycoprotein in Pharmacokinetics:
Clinical Implications. Clin. Pharmacokinet. 42:1 (2003) 59-98.
LÖSCHER, W. (1984) – Genetic animal models of epilepsy as a unique response for
the evaluation of anticonvulsant drugs. A review. Methods. Find. Exp. Clin.
Pharmacol. 6:9 (1984) (abstract).
VII. BIBLIOGRAFIA | 153
LÖSCHER, W. [et al.] (1998) – Seizure Supression in Kindling Epilepsy by Grafts of
Fetal GABAergic Neurons in Rat Substantia Nigra. J. Neuros. Res. 51 (1998) 196209.
LÖSCHER, W. (2002) – Animal models of epilepsy for the development of
antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology
of Kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy
Res. 50 (2002) 105-123.
LÖSCHER, W.; NOLTING, B.; FASSBENDER, C.P. (1990) – The role of technical,
biological and pharmacological factors in the laboratory evaluation of
anticonvulsant drugs. I. The influence of administration vehicles. Epilepsy Res. 7:3
(1990) 173-181.
LÖSCHER, W.; FASSBENDER, C.P.; NOLTING, B.(1991) – The role of technical,
biological and pharmacological factors in the laboratory evaluation of
anticonvulsant drugs II. Maximal electroshock seizure models. Epilepsy Res. 8
(1991) 79-94.
LÖSCHER, W.; FIEDLER, M. (2000) – The role of technical, biological and
pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII.
Seasonal influences on anticonvulsant drug actions in mouse models of generalized
seizures. Epilepsy Res. 38 (2000) 231-248.
LÖSCHER, W.; JÄCKEL, R.; CZUCZWAR, S.J. (1986) – Is Amygdala Kindling in rats a
model for drug-resistant epilepsy? Exp. Neurol. 93:1 (1986) 211-226.
LÖSCHER, W.; LEHMANN, H. (1996) – L-Deprenyl (Selegiline) Exerts
Anticonvulsant Effects Against Different Seizure Types in Mice. J. Pharm. Exp.
Ther. 277:3 (1996) 1410-1417.
LÖSCHER, W.; POTSCHKA, H. (2002) – Role of Multidrug Transporters in
Pharmacoresistance to Antiepileptic Drugs. J. Pharm. Exp. Ther. 301:1 (2002) 7-14.
LÖSCHER, W.; SCHMIDT, D. ( 1988) – Which animals models should be used in the
search for new antepileptic drugs? – A proposal based on experimental and clinical
considerations. Epilepsy Res. 2 (1988) 145-181.
154 | Perfil anticonvulsivante da lamotrigina em ratos
LÖSCHER, W.; SCHMIDT, D. (1994) – Strategies in antiepiletic drug development: is
rational drug design superior to random screening and structural variation? Epilepsy
Res. 17 (1994) 95-134.
LÖSCHER, W.; WAUQUIER, A. (1996) – Use of animal models in developing guiding
principles for polypharmacy in epilepsy. Epilepsy. Res. Suppl 11 (1996) 61-65.
LOWENSTEIN, D.H. (2002) – Convulsões e Epilepsia. In HARRISON, T.R. - Medicina
Interna. Rio de Janeiro: Mc Graw Hill; 15ª ed., 2002. Vol II chapter 360: p.25012517.
MAHMOOD, I.; TAMMARA, V.; BAWEJA, R. (1998) – Does percent reduction in
seizure frequency correlate with plasma concentration of anticonvulsant drugs?Experience with four anticonvulsant drugs. Clin. Pharmacol. Ther. 64 (1998) 547552.
MAUGUIERE, F.; ISNARD, J. (1995) – Le diagnostic des épilepsies de l’adulte:
diagnostic clinique et electro-encéphalographique. Conc. Méd. 117:29 (1995) 2227-2231.
MELDRUM, B.S. (1997) – Identification and preclinical testing of novel antiepileptic
compounds. Epilepsia. 38 (1997) (abstract).
MESSENHEINER, J.A. (1995) – Lamotrigine. Epilepsia. 36: Suppl 2 (1995) S87-S94.
MILLER, A.A. [et al.] (1986a) – Lamotrigine. In MELDRUM, B.L.; PORTER, R.J., ed.
lit. – Currents problems in epilepsy. 4-New antiepileptic drugs. London: John
Libbey & Co., 1986. Chapter 12: p.165-177.
MILLER, A.A. [et al.] (1986b) – Pharmacological Studies on Lamotrigine, A novel
Potential Antiepileptic Drug: I. Anticonvulsant profile in Mice and Rats. Epilepsia.
27:5 (1986) 483-489.
NOVACK, G.D.; STARK, L.G.; PETERSON, S. (1978) – Anticonvulsant effects of
Bezhydryl Piperazines on Maximal Electroshock Seizures in Rats. J. Pharm. Exp.
Ther. 208:3 (1978) 480-484.
VII. BIBLIOGRAFIA | 155
OTSUKI, K. [et al.] (1998) – Effects of lamotrigine and conventional antiepileptic
drugs on amygdala and hippocampal-kindled seizures in rats. Epilepsy Res. 31
(1998) 101-112.
PARSONS, D.N.; DICKINS, M.; MORLEY, T.J. (1985) – Lamotrigine: Absorption,
Distribution, and Excretion. In LEVY, R.H.; MATTSON, R.H.; MELDRUM, B.S. ed. lit.
- Antiepileptic Drugs. 4th ed. New York: Raven Press Ltd., 1995. Chapter 78: p.
877-881.
PASCHOA, O.E.D. [et al.] (2000) – Pharmacokinetic-Pharmacodynamic correlation
of lamotrigine, flunarizine, loreclezole, CG0116 and CGP39551 in the cortical
stimulation model. Epilepsy Res. 40 (2000) 41-52.
PASQUA, O., E.D. [et al.] (2001) – Preclinical Pharmacokinetic-Pharmacodynamic
Modelling
of
the
Anticonvulsant
Effect
[on
line][08-10-2002]
WWW:URL:http://www.clinsight.com/anticonvulsant/chapt1.htm.
PERUCCA, E. (2002) – Marketed New Antieplipertic Drugs: Are they better Than
Old-Generation Agents? Ther. Drug. Monit. 24:1 (2002) 74-80
PIREDDA, S.; WOODHEAD, J.H.; SWINYARD, E.A. (1984) – Effect of Stimulus
Intensity on the Profile of Anticonvulsant Activity of Phenytoin, Ethosuximide and
Valproate. J. Pharm. Exp. Ther. 232:3 (1984) 741-745.
POSTMA, T. [et al.] (2000) – Lamotrigine Treatment During Amygdala-kindled
Seizure Development Fails to Inhibit Seizures and Diminishes Subsequent
Anticonvulsant Efficacy. Epilepsia. 41:12 (2000) 1514-1521.
POTSCHKA, H.; FEDROWITZ, M.; LÖSCHER, W. (2002) – P-Glycoprotein-mediated
efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier:
evidence from microdialysis experiments in rats. Neurosci. Letters. 327 (2002)
173-176.
RAGSDALE, D.; AVOLI, M. (1998) – Sodium channels as molecular targets for
antiepileptic drugs. Brain Res. Rev. 26 (1998) 16-28.
RAMBECK, B.; WOLF, P. (1993) – Lamotrigine Clinical Pharmacokinetics. Clin.
Pharmacokinet. 25:6 (1993) 433-443.
156 | Perfil anticonvulsivante da lamotrigina em ratos
RAMZAN, I.; LEVY;G. (1989) – Relationship Between Concentration and
Anticonvulsant Effect of Phenytoin Against Electroshock-Induced Seizures in Rats:
Comparison of Sampling Sites for Concentration Determinations. J. Pharm. Sci.
78:6 (1989) 448-451.
RANG, H.P.; DALE, M. M.;RITTER,J.M. (2001) – Drogas antiepilépticas e relaxantes
musculares de acção central. Farmacologia. Rio de Janeiro. ed. Guanabara Koogan.
S.A. (2001) Vol 1, chapter 37: p.474-484.
RATAUD, J. et al. (1994) – Comparative study of voltage-sensitive sodium channel
blockers in focal ischaemia and electric convulsions in rodents. Neurosci. Letters.
172 (1994) 19-23.
RCM – Resumo das características do medicamento (1999). Lisboa: INFARMED,
1999. 11p.
SCHWINGHAMMER, T.; KROBOTH, P. (1988) – Basic Concepts in Pharmacodynamic
Modeling. J. Clin. Pharmacol. 28 (1988) 388-394.
SIMPSON, D.M. [et al.] (2003) – Lamotrigine for HIV-associated painful sensory
neuropathies. Neurology. 60 (2003) 1508-1514.
SMITH D. [et al.] (1993) – Outcome of add-on treatment with lamotrigine in partial
epilepsy. Epilepsia. 34 (1993) 312-322.
STEFANI, A. [et al.] (1996) – Lamotrigine inhibits Ca2+currents in cortical neurons:
functional implications. Eur. J. Pharmacol. 307:1 (1996) 113-116.
SWINYARD, E.A.; BROWN, W.C.; GOODMAN, L.S. (1957) – Comparative assays of
antiepileptic drugs in mice and rats. J. Pharm. Exp. Ther. 106 (1952) 319-330.
SWINYARD, E.A.; KUPFERBERG, H.J. (1985) – Antiepileptic drugs: detection,
quantification, and evaluation. Federation Proc. 44:10 (1985) 1-5.
VII. BIBLIOGRAFIA | 157
TEDESCHI, D.H.; SWINYARD, E.A.; GOODMAN, L.S. (1956) – Effects of variations in
stimulus intensity on maximal electroshock seizure pattern, recovery time, and
anticonvulsant potency of phenobarbital in mice. J. Pharmacol. Exp. Ther. 116
(1956) 107-118.
TEOH, H. [et al.] (1995) – Effect of lamotrigine on the electrically-evoked release of
endogenous amino-acids from slices of dorsal horn of the rat spinal cord.
Neuropharmacol. 34 (1995) 1273-1278.
TOMAN, J.E.P.; SWINYARD, E.A.; GOODMAN, L.S. (1946) – Properties of maximal
seizures, and their alteration by anticonvulsant drugs and other agents.
J. Neurophysiol. 9 (1946) 231-240.
URE, J.A.; PERASSOLO, M. (2000) – Update on the pathophysiology of the
epilepsies-review article. J. Neur. Sci. 177 (2000) 1-17.
WALKER, M.C. et al. (2000) – Comparison of serum, cerebrospinal and brain
extracellular fluid pharmacokinetics of lamotrigine. Br. J. Pharmacol. 130:2 (2000)
242-248.
WALTON, N.Y. et al. (1996) – Lamotrigine vs phenytoin for treatment of status
epilepticus: comparison in an experimental model. Epilepsy Res. 24:1 (1996) 19-28.
WANG, S.J.; TSAI, J.J.; GEAN, P.W. (1998) – Lamotrigine Inhibits Depolarization-Evoked Ca2+ Influx in Dissociated Amygdala Neurons. Synapse. 29 (1998) 355-362.
WEATHLEY, P.L.; MILLER, A.A. (1989) – Effects of Lamotrigine on Electrically
Induced Afterdischarge Duration in Anesthesied Rat, Dog, and Marmoset.
Epilepsia. 30:1 (1989) 34-40.
WHITE, H.S. (1997) – Clinical Significance of Animal Seizure Models and
Mechanism of Action Studies of Potential Antiepileptic drugs. Epilepsia. 38:
Suppl 1 (1997) S9-S17.
WHITE, H.S. (1999) – Comparative Anticonvulsant and Mechanism Profile of the
Established and Newer Antiepileptic Drugs. Epilepsia. 40: Suppl 5 (1999) S2-S10.
158 | Perfil anticonvulsivante da lamotrigina em ratos
WINNONLIN Version 1.1.(1996). Palo Alto (CA): Pharsight Corporation Inc., 1996.
WOLF, P. (1997) – International Classification of the Epilepsies. In ENGEL, J.;
PEDLEY, T.A. ed. lit. – Epilepsy: A Comprehensive Textbook. Philadelphia:
Lippincott-Raven Publishers, 1997. Vol 1, chapter 68: p. 773-777.
WOODBURY, L.A.; DAVENPORT, V.D. (1952) – Design and use of a new
electroshock seizure apparatus, and analysis of factors altering seizure threshold and
pattern. Arch. Int. Pharmcodyn. Ther. 92 (1952) 97-107.
XIE, X. [et al.] (1995) – Interaction of the antiepileptic drug lamotrigine with
recombinant rat brain type II Na + changes and with native Na + channels in rat
hippocampal neurons. Pfügers Arch. 430 (1995) 437.
ZABLOCKA, B.; ESPLIN, D.W. (1964) – Role of seizure spread in determining
maximal convulsion pattern in rats. Arch. Int. Pharmcodyn. 147 (1964) 525-542.
ZONA, C. [et al.] (2002) – Neocortical Potassium Currents Are Enhanced by the
Antiepileptic Drug Lamotrigine. Epilepsia. 43:7 (2002) 685-690.
VII. BIBLIOGRAFIA | 159
160 | Perfil anticonvulsivante da lamotrigina em ratos
VII. BIBLIOGRAFIA | 161